Farmak Pharmaceutical Company (JSC Farmak, Kyiv) has started exporting to Pakistan, the first product supplied is an injectable drug for general anesthesia, which is also registered in the UK.
According to the company’s press release, Pakistan became the second country in South Asia after Jordan to which Farmak supplies its products. Farmak’s presence in the region is ensured by the Farmak International Middle East & Africa team.
In general, Farmak exports its products to more than 60 countries, including 15 EU countries, as well as countries of Central and South America, the Middle East, Asia, Africa and Australia.
As reported, in 2023, Farmak increased its net profit by 18% compared to 2022, to UAH 1.557 billion.
Farmak Group is the leader of the Ukrainian pharmaceutical market in monetary terms, has two production sites in Ukraine and a production site in Spain, as well as 11 international representative offices and marketing and distribution companies in countries such as Poland, Czech Republic, Slovakia, the United Kingdom, the United Arab Emirates, Vietnam, Switzerland, Kazakhstan, Uzbekistan, Kyrgyzstan, and Moldova. The ultimate beneficial owner of Farmak is the Chairman of the Supervisory Board Filya Zhebrovska (80% of the company’s shares).
